- Search for Research Summaries, Reviews, and Reports
- DEcIDE Project
- Data Points #1: Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006-2008.
Data Points Publication Series
- Data Points Publication Series
- Data Points #2: Incidence of diabetic foot ulcer and lower extremity amputation among Medicare beneficiaries, 2006-2008.
- Data Points #3: Economic burden of diabetic foot ulcers and amputations
- Data Points #4: Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease
- Data Points #5: Prevalence and Medicare Reimbursement by Recurrent International Classification of Diseases Categories, 2006-2009
- Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009
- Data Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009
- Data Points #8: Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009
- Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009
- Data Points #10: Proton beam radiotherapy in the U.S. Medicare population: growth in use between 2006 and 2009
- Data Points #11: Newly Medicare-eligible disabled: comparison of duals and nonduals
- Data Points #12: Health care use in the first six months of Medicare eligibility for elders: Impact of State support
- Data Points #13: Use of preoperative MRI among older women with ductal carcinoma in situ and locally invasive breast cancer
- Data Points #14: Use of endocrine therapy following diagnosis of ductal carcinoma in situ or early invasive breast cancer
- Data Points #15: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer
- Data Points #16: Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients: 2006-2008
- Data Points #18: Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011
- Data Points #17: Trends in bariatric surgery in Medicare beneficiaries
- Data Points #19: Medication Use in Medicare
- Data Points #20: Echocardiography Trends
Research Report - Final – Feb. 17, 2011
Data Points #1: Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006-2008.
People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us.
Note: This report is greater than 5 years old. Findings may be used for research purposes but should not be considered current.
The prevalence of diabetes in the Medicare population may be one-third higher than previously estimated.
Overall, approximately 8% of diabetic Medicare beneficiaries have a foot ulcer and 1.8% have an amputation. These prevalence rates are further elevated for the subset of beneficiaries with lower extremity peripheral artery disease.
The prevalence rates for foot ulcer and lower extremity amputation among diabetic Medicare beneficiaries vary dramatically by geographic region.
More than 16 million people in the United States (U.S.) have diabetes mellitus. The prevalence of diabetes among those over 65 years of age was last estimated by the Centers for Disease Control and Prevention (CDC) using 2008 data from the National Health Interview Survey. It is about 19.9 percent among those ages 65 to 74 and 17.1 percent among those more than 75 years of age. These estimates are based on self-reports and are thought to underestimate the true prevalence by one-third (www.cdc.gov/diabetes/statistics/prev/national/figbyage.htm). Those with diabetes are expected to suffer from several associated medical complications, such as renal disease, cardiac disease, and retinopathy. In addition, between 10 and 15 percent of those with diabetes can expect to develop a foot ulcer at some point in their lives. Lower extremity amputation (LEA) is a less common complication associated with diabetes and foot ulcer. Both foot ulcer and amputation vary by geographic location.
Diabetic foot ulceration can develop because of acute or chronic cutaneous compromise of the skin, arterial insufficiency, peripheral neuropathy, or a combination of these factors. In fact, approximately 20 percent of diabetic patients with foot ulcers will primarily display inadequate peripheral arterial supply (also called peripheral arterial disease, PAD), about 50 percent will primarily display peripheral neuropathy, and about 30 percent will display a combination of both conditions (i.e., neuroischemia). The prevalence of PAD among those with foot ulcers has recently been shown to be increasing and now the majority likely has PAD or neuroischemia.
In 2003, CDC, based on the National Hospital Discharge Survey, reported a rate of 8 (ages 65–74) to 11 (age 75 and greater) hospital discharges with a diagnosis of foot ulcer per 1,000 individuals with diabetes. This report was limited because it did not include outpatient care or chronic care facilities, may have counted individuals with venous leg ulcers, and may have counted individuals more than once if they were hospitalized more than once. Using the same dataset, CDC estimated in 2005 that the rate of LEA was 5.3 to 5.6 hospital discharges per 1,000 individuals with diabetes.
These rates have been shown to vary by age, gender, race/ethnicity, and health care region.
Improving the quality and effectiveness of management of diabetes mellitus and, in particular, lower extremity wounds in diabetic patients may diminish the incidence of unnecessary or inadequate LEAs. It also may improve success in the treatment of lower extremity wounds. The goal of this Data Points brief is to explore the prevalence of diabetes, foot ulcer, and LEA in Medicare beneficiaries. Please refer to companion briefs for separate discussions of the incidence of diabetes, foot ulcer, LEA, and reamputation; the rate of death among Medicare beneficiaries with foot ulcer or amputation; the rate of other diabetes-related complications with respect to diagnosis of foot ulcer and LEA; and medical utilization and costs associated with foot ulcers and amputation.
Prevalence of Diabetes
In the population of beneficiaries with at least 12 months of continuous enrollment in Medicare Parts A and B Fee-for-Service (FFS) plans (see Data Source section), the prevalence of diabetes was 26.4 percent in 2006, 27.3 percent in 2007, and 27.9 percent in 2008. As expected, this is about one-third higher than previous CDC prevalence estimates. Approximately 8.7, 8.8, and 8.9 million participants had diabetes mellitus in 2006, 2007, and 2008, respectively. More specifically, for beneficiaries age 65 years and over, the prevalence was 26.5 percent in 2006, 27.4 percent in 2007, and 28.0 percent in 2008. These rates varied by age, gender, race/ethnicity, and geographic location. For example, in 2008, the prevalence of diabetes mellitus was 29.1 percent for males and 26.9 percent for females. The prevalence of diabetes by race was 26.2 percent for white, 38.2 percent for African American, 36.8 percent for Asian, 39.8 percent for Hispanic, 37.9 percent for American Indian/Alaska Native, and 33.4 percent for other. Geographic distribution of diabetes mellitus prevalence varied widely based on Dartmouth Atlas of Health Care Hospital Referral Regions (HRRs) (www.dartmouthatlas.org/) but varied little by year.
Prevalence of Foot Ulcer
We used the population of beneficiaries who were continuously enrolled for at least 12 months in Medicare Parts A and B FFS plans, as defined in the Data Source section, and also continuously enrolled in the calendar year, hereafter referred to as the Medicare FFS population. The yearly prevalence of foot ulcer in the subpopulation of Medicare FFS beneficiaries with diabetes was 8.1 percent in 2006, 8.1 percent in 2007, and 8.0 percent in 2008. The prevalence of foot ulcer in the subpopulation of Medicare FFS beneficiaries with diabetes and PAD was about twice as high, with yearly prevalence rates of 19.2 percent in 2006, 18.9 percent in 2007, and 18.6 percent in 2008. These rates varied by age, gender, race/ethnicity, and geographic location. For example, in 2008, the prevalence of foot ulcer among the subpopulation of Medicare FFS beneficiaries with diabetes was 8.2 percent for males and 7.8 percent for females. The prevalence of foot ulcer among those in the subpopulation of Medicare FFS beneficiaries with diabetes by race in 2008 was 8.0 percent for white, 8.7 percent for African American, 4.2 percent for Asian, 8.6 percent for Hispanic, 9.6 percent for American Indian/Alaska Native, and 5.5 percent for other. These overall yearly prevalence rates varied little from 2006 to 2008. Geographic distribution of prevalent foot ulcer among those with diabetes mellitus varied widely (and slightly by year) based on Dartmouth Atlas of Health Care HRRs.
Prevalence of Lower Extremity Amputation
We used the Medicare FFS population (beneficiaries continuously enrolled for at least 12 months in Medicare Parts A and B FFS, as defined in the Data Source section, and also continuously enrolled in the calendar year). The yearly prevalence of LEA (all or part of a leg or foot) in the subpopulation of Medicare FFS beneficiaries with diabetes was 1.8 percent in 2006, 2007, and 2008. The prevalence of LEA in the subpopulation of Medicare FFS beneficiaries with diabetes and PAD was about three times as high, with yearly prevalence rates of 6.5 percent in 2006, 6.1 percent in 2007, and 5.9 percent in 2008. The prevalence of LEA in nonelderly diabetics with PAD (many of whom likely have end-stage renal disease, since they are receiving Medicare benefits before age 65) was nearly seven times as high as the prevalence in the Medicare FFS population with diabetes. Yearly prevalence rates were 14.7 percent in 2006, 14.0 percent in 2007, and 13.9 percent in 2008. These rates varied by age, gender, race/ethnicity, and geographic location. For example, in 2008, the prevalence of LEA was 2.3 percent for male diabetics and 1.3 percent for female diabetics. By race/ethnicity, the prevalence of LEA among those with diabetes was 1.5 percent for white, 3.3 percent for African American, 0.7 percent for Asian, 2.6 percent for Hispanic, 3.8 percent for American Indian/Alaska Native, and 1.5 percent for other. Geographic distribution of prevalent LEA among those with diabetes mellitus varied widely based on Dartmouth Atlas of Health Care HRRs. Finally, the prevalence of major amputation in 2008 was 1.3 percent and minor amputation was 0.46 percent. The yearly prevalence rates varied little from 2006 to 2008.